All In MedTech

FDA Clearance Tracker · P020045-S073

FREEZOR XTRA SURGICAL CARDIAC CRYOABLATION DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 31, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 31, 2016

Approved

Time to decision

216 days

Received Jan 28, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P020045-S073
Device name
FREEZOR XTRA SURGICAL CARDIAC CRYOABLATION DEVICE
Applicant location
Mounds View, MN
Received
Jan 28, 2016
Decided
Aug 31, 2016
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P020045

Device type

Device class
Class III

Every decision under product code LPB

FDA's approval statement

As written in FDA's record.

Approval for the Freezor Xtra Cardiac CryoAblation Catheter, CryoConsole system, and related accessories. The device is indicated for the cryoablation of the conducting tissues of the heart in the treatment of patients with atrioventricular nodal reentrant tachycardia (AVNRT). The Freezor Xtra catheter is also intended for minimally invasive cardiac surgery procedures, including surgical treatment of cardiac arrhythmias. The Freezor Xtra catheter freezes the target tissue and blocks the electrical conduction by creating an inflammatory response or cryonecrosis.

Source documents

Other decisions for Medtronic Cryocath, LP

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.